John Kiely Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity

John Kiely is Director of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 267,175 shares of AMRX, which is worth approximately $2.1 Million. The most recent transaction as insider was on Nov 22, 2024, when has been sold 17,058 shares (Class A Common Stock) at a price of $8.38 per share, resulting in proceeds of $142,946. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 267K

4.48% 3M change

49.03% 12M change

Total Value Held $2.1 Million

John Kiely Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 22 2024	SELL Open market or private sale	$142,946 $8.38 p/Share	17,058 Reduced 6.0%	267,175 Class A Common Stock
Nov 22 2024	BUY Exercise of conversion of derivative security	$135,688 $4.76 p/Share	28,506 Added 9.11%	284,233 Class A Common Stock
May 10 2024	BUY Exercise of conversion of derivative security	-	76,453 Added 23.02%	255,727 Class A Common Stock
May 10 2023	BUY Exercise of conversion of derivative security	-	80,128 Added 30.89%	179,274 Class A Common Stock
May 08 2022	BUY Exercise of conversion of derivative security	-	35,406 Added 26.31%	99,146 Class A Common Stock
May 06 2021	BUY Exercise of conversion of derivative security	-	46,218 Added 42.03%	63,740 Class A Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	-	7,522 Added 30.04%	17,522 Class A Common Stock

Also insider at

ZVO

Zovio Inc Consumer Defensive

Director

John Kiely

Director

Chandler, AZ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Value

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX

Account